The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin

RG Pertwee - British journal of pharmacology, 2008 - Wiley Online Library
Cannabis sativa is the source of a unique set of compounds known collectively as plant
cannabinoids or phytocannabinoids. This review focuses on the manner with which three of …

Evidence for the risks and consequences of adolescent cannabis exposure

A Levine, K Clemenza, M Rynn, J Lieberman - Journal of the American …, 2017 - Elsevier
Objective This review of the scientific literature examines the potential adult sequelae of
exposure to cannabis and related synthetic cannabinoids in adolescence. We examine the …

A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol

E Russo, GW Guy - Medical hypotheses, 2006 - Elsevier
This study examines the current knowledge of physiological and clinical effects of
tetrahydrocannabinol (THC) and cannabidiol (CBD) and presents a rationale for their …

Cannabinoids and pain: sites and mechanisms of action

K Starowicz, DP Finn - Advances in Pharmacology, 2017 - Elsevier
The endocannabinoid system, consisting of the cannabinoid 1 receptor (CB 1 R) and
cannabinoid 2 receptor (CB 2 R), endogenous cannabinoid ligands (endocannabinoids) …

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

RG Pertwee - British journal of pharmacology, 2009 - Wiley Online Library
Mandarin translation of abstract Medicines that activate cannabinoid CB1 and CB2 receptor
are already in the clinic. These are Cesamet®(nabilone), Marinol®(dronabinol; Δ9 …

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond

RG Pertwee - Addiction biology, 2008 - Wiley Online Library
ABSTRACT A major finding—that (–)‐trans‐Δ9‐tetrahydrocannabinol (Δ9‐THC) is largely
responsible for the psychotropic effects of cannabis—prompted research in the 1970s and …

Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1–dependent withdrawal

L Deng, J Guindon, BL Cornett, A Makriyannis… - Biological …, 2015 - Elsevier
Background Mixed cannabinoid receptor 1 and 2 (CB 1 and CB 2) agonists such as Δ 9-
tetrahydrocannabinol (Δ 9-THC) can produce tolerance, physical withdrawal, and unwanted …

The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids

RG Pertwee - Drug addiction: from basic research to therapy, 2008 - Springer
There are at least 2 types of cannabinoid receptor, CB 1 and CB 2, both G protein coupled.
CB 1 receptors are expressed predominantly at nerve terminals and mediate inhibition of …

Paracetamol (acetaminophen) administration during neonatal brain development affects cognitive function and alters its analgesic and anxiolytic response in adult …

H Viberg, P Eriksson, T Gordh… - Toxicological …, 2014 - academic.oup.com
Paracetamol (acetaminophen) is one of the most commonly used drugs for the treatment of
pain and fever in children, both at home and in the clinic, and is now also found in the …

Pharmacological characterization of the chronic constriction injury model of neuropathic pain

J De Vry, E Kuhl, P Franken-Kunkel, G Eckel - European journal of …, 2004 - Elsevier
The chronic constriction injury model is a rat model of neuropathic pain based on a
unilateral loose ligation of the sciatic nerve. The aim of the present study was to test its …